Skandinaviska Enskilda Banken (SEB)’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,526
| Closed | -$709K | – | 956 |
|
|
2023
Q1 | $709K | Sell |
17,526
-812
| -4% | -$32.8K | 0.01% | 730 |
|
|
2022
Q4 | $853K | Sell |
18,338
-1,062
| -5% | -$49.4K | 0.01% | 685 |
|
|
2022
Q3 | $1.01M | Hold |
19,400
| – | – | 0.01% | 679 |
|
|
2022
Q2 | $917K | Hold |
19,400
| – | – | 0.01% | 724 |
|
|
2022
Q1 | $1.38M | Buy |
19,400
+5,259
| +37% | +$374K | 0.01% | 696 |
|
|
2021
Q4 | $1.05M | Buy |
+14,141
| New | +$1.05M | 0.01% | 763 |
|
|
2020
Q3 | – | Sell |
-9,400
| Closed | -$472K | – | 1054 |
|
|
2020
Q2 | $472K | Sell |
9,400
-21,900
| -70% | -$1.1M | ﹤0.01% | 820 |
|
|
2020
Q1 | $1.61M | Sell |
31,300
-1,900
| -6% | -$97.7K | 0.02% | 528 |
|
|
2019
Q4 | $2.05M | Buy |
33,200
+4,300
| +15% | +$266K | 0.02% | 560 |
|
|
2019
Q3 | $1.74M | Buy |
28,900
+4,900
| +20% | +$294K | 0.01% | 574 |
|
|
2019
Q2 | $2.03M | Sell |
24,000
-5,900
| -20% | -$498K | 0.02% | 510 |
|
|
2019
Q1 | $2.86M | Sell |
29,900
-4,600
| -13% | -$439K | 0.03% | 388 |
|
|
2018
Q4 | $2.44M | Buy |
+34,500
| New | +$2.44M | 0.02% | 422 |
|
|
2016
Q3 | – | Sell |
-67,900
| Closed | -$1.5M | – | 716 |
|
|
2016
Q2 | $1.5M | Sell |
67,900
-88,500
| -57% | -$1.95M | 0.02% | 524 |
|
|
2016
Q1 | $4.59M | Sell |
156,400
-36,100
| -19% | -$1.06M | 0.05% | 257 |
|
|
2015
Q4 | $6.44M | Buy |
+192,500
| New | +$6.44M | 0.08% | 186 |
|